학술논문

PRELIMINARY RESULTS OF A PHASE 2 STUDY OF INTRATUMORAL ADMINISTRATION OF BO-112 WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED MELANOMA THAT HAVE PROGRESSIVE DISEASE ON ANTI-PD-1-BASED THERAPY